Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways. [electronic resource]
Producer: 20201014Description: 859-862 p. digitalISSN:- 1365-2133
- Adult
- Biopsy
- Cytokines -- metabolism
- Double-Blind Method
- Female
- Humans
- Injections, Subcutaneous
- Male
- Methotrexate -- administration & dosage
- Placebos -- administration & dosage
- Prospective Studies
- Psoriasis -- drug therapy
- Signal Transduction -- drug effects
- Skin -- cytology
- Th1 Cells -- drug effects
- Th17 Cells -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Letter; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.